...ALK-negative ALCL, survival remains poor in PCNSL. We report a case of PCNSL ALK-negative ALCL with DUSP22-IRF4 rearrang...
...ALK-negative status and high Ki-67 expression are generally associated with poor outcomes in ALCL patients. Systemic ALK...
...ALK)-positive anaplastic large cell lymphoma who developed extensive CVST shortly after initiation of chemotherapy. He p...
...ALK, ROS1, BRAF, KRAS, NTRK1/2/3, MET, RET, and HER2. Among the 124 patients who met the inclusion criteria, the overall...
...ALK, and TPR::NTRK1). Furthermore, NGS definitively segregated true Spitz neoplasms from morphologic mimics (MSF), which...
...ALKS 2680) is a highly potent, oral, selective orexin 2 receptor (OX2R) agonist in clinical development for IH, NT2 and ...
...ALK Positive Europe, and Women Against Lung Cancer in Europe, illustrating a decentralized yet strongly patient-led advo...
...ALK-negative ALCL, and secondary mycosis fungoides. Imaging revealed four major patterns, and symptoms were largely due ...
...ALK-positive IMT. On the contrary, ALK-negative IMT harbours distinct oncogenic fusions and is driven by diverse signall...
...ALK fusion prevalence across 21 European countries. Marjanski and colleagues expose critical gaps in real-world perioper...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
